PLOS Medicine - Číslo 7/2011
Editorial
Essay
Perspective
Health in Action
Policy Forum
Research Article
32767
PLOS Medicine
2011 Číslo 7
Nejčtenější v tomto čísle
- Individualized Cost-Effectiveness Analysis
- GeneXpert—A Game-Changer for Tuberculosis Control?
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
- Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort